OVERVIEW Position Number: LA 001 Grade: D-2 Parent Sector: Office of International Standards and Legal Affairs (LA) Duty Station: Paris Job Family: Law Contract Type: Fixed Term Duration of contract: 2 years, renewable Recruitment open to:
Job Title: Civil Estimator Location: Paris, Texas Salary: $65,000 – $100,000 per year (Based on experience) Job Type: Full-Time Schedule: Monday – Friday About Us At Harrison, Walker & Harper (HWH), we’ve been building more than
Façonner l’avenir de la logistique- Votre carrière commence chez Röhlig Quil sagisse du transport maritime, du transport aérien ou de la logistique contractuelle, chez Röhlig Logistics, vous contribuerez à élaborer des solutions sur mesure qui font
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Deadline for Applications August 12, 2026 Hardship Level H (no hardship) Family Type Family Residential location (if applicable) Grade GS7 Staff Member / Affiliate Type General Service ReasonRegular Regular Assignment Target Start Date 2026-10-01 Standard Job
Retail Merchandiser Department: Field Employment Type: Part Time Location: Paris, TX Description Are you an energetic self-starter? Are you interested in making your own schedule? Neptune Retail Solutions has immediate availability for a Part-time Retail Merchandiser
Company Description Ennismore is a hospitality company rooted in culture and community, with a global collective of entrepreneurial and founder-built brands with creativity and purpose at their heart. Ennismore is a joint venture with Accor, formed
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Location: Sofia, Bulgaria Start Date: 14/08 Are you fluent in French (C1) and English, passionate about online safety, and ready to contribute to a secure and compliant digital experience? Join us as a Digital Trust and